Main Article Content
EZH2, JAK2, METTL3, pediatric pneumonia, STAT
Background: In recent times, the medical science has developed by leaps and bounds, however, the molecular mechanism of pediatric pneumonia is still unclear. Although prior researches have shown that methyltransferase-like 3 (METTL3) is up-regulated in a variety of inflammatory diseases, its role and mechanism has been rarely studied in pediatric pneumonia, and need to be defined elaborately.
Objective: In this study, the related molecular mechanism of METTL3 on inflammation and cell apoptosis in a pediatric pneumonia was investigated.
Materials and methods: Quantitative real-time polymerase chain reaction (qPCR) and western blot assays were employed to examine the mRNA and protein expression level of METTL3 and EZH2 in peripheral blood monocytes from pediatric pneumonia patients or cell model (WI-38). Then, qPCR and ELISA assay were applied to verify the inflammatory response in LPS-treated WI-38 cell lines after knockdown of METTL3. Besides, MTT cell viability assays, flow cytometry, and western blot assays were applied to examine the cell viability and cell apoptosis of LPS-treated WI-38 cell after knockdown of METTL3. Further, the western blot assays were employed to examine the protein expression levels of p-JAK2, JAK2, p-STAT3, STAT3, and EZH2 in LPS-treated WI-38 cell after knockdown of METTL3. Finally, ELISA and western blot were applied to verify the inflammatory response and cell apoptosis of LPS-treated WI-38 cell after knockdown of METTL3 and overexpression of EZH2.
Results: In this study, the results showed that METTL3 and EZH2 were highly expressed in pediatric pneumonia patients and cell models (WI-38), respectively. Besides, downregulation of METTL3 inhibited LPS-induced inflammatory response and cell apoptosis. Then, the fact that METTL3 regulates the JAK2/STAT3 signaling pathway through EZH was proved. Furthermore, downregulation of METTL3 inhibits inflammation and apoptosis through EZH2.
Conclusion: This study found that METTL3 promotes inflammation and cell apoptosis in a pediatric pneumonia model by regulating EZH2.
2. Zhang L, Dong L, Tang Y, Li M, Zhang M. MiR-146b protects against the inflammation injury in pediatric pneumonia through MyD88/NF-κB signaling pathway. Infect Dis (London). 2020;52(1):23–32. https://doi.org/10.1080/23744235.2019.1671987
3. Piao X, Zou Y, Sui X, Liu B, Meng F, Li S, et al. Hydrostatin-SN10 ameliorates pancreatitis-induced lung injury by affecting IL-6-induced JAK2/STAT3-associated inflammation and oxidative stress. Oxid Med Cell Longev. 2019;2019:9659757. https://doi.org/10.1155/2019/9659757
4. Li R, Hong P, Zheng X. β-carotene attenuates lipopolysaccharide-induced inflammation via inhibition of the NF-κB, JAK2/STAT3 and JNK/p38 MAPK signaling pathways in macrophages. Anim Sci J (Nihon Chikusan Gakkaiho). 2019;90(1):140–8. https://doi.org/10.1111/asj.13108
5. Yu Y, Zhu T, Li Y, Jing L, Yang M, Li Y, et al. Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2/STAT3 and TGF-β/Smad3 pathways in vivo. Int J Nanomed. 2019;14:7237–47. https://doi.org/10.2147/IJN.S209458
6. Wang J, Yan S, Lu H, Wang S, Xu D. METTL3 attenuates LPSinduced inflammatory response in macrophages via NF-κB signaling pathway. Mediators Inflamm. 2019;2019:3120391. https://doi.org/10.1155/2019/3120391
7. Feng Z, Li Q, Meng R, Yi B, Xu Q. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide induced inflammatory response in human dental pulp cells. J Cell Mol Med. 2018;22(5):2558–68. https://doi.org/10.1111/jcmm.13491
8. Liu Q, Li M, Jiang L, Jiang R, Fu B. METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte. Biochem Biophy Res Commun. 2019;516(1):22–7. https://doi.org/10.1016/j.bbrc.2019.05.168
9. Wu R, Liu Y, Zhao Y, Bi Z, Yao Y, Liu Q, et al. m(6)A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/ YTHDF2-orchestrated manner. Cell Death Dis. 2019;10(3):171. https://doi.org/10.1038/s41419-019-1417-4
10. Meng QZ, Cong CH, Li XJ, Zhu F, Zhao X, Chen FW. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2. Eur Rev Med Pharm Sci. 2020;24(8):4328–36. https://doi.org/10.26355/eurrev_202004_21014
11. Liang H, Huang Q, Liao MJ, Xu F, Zhang T, He J, et al. EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling. Inflamm Res Off J Eur Histamine Res Soc. 2019;68(4):325–36. https://doi.org/10.1007/s00011-019-01221-3
12. Hui T, Peng A, Zhao Y, Yang J, Ye L, Wang C. EZH2 regulates dental pulp inflammation by direct effect on inflammatory factors. Arch Oral Biol. 2018;85:16–22. https://doi.org/10.1016/j.archoralbio.2017.10.004
13. Lee S, Woo DC, Kang J, Ra M, Kim KH, Lee SR, et al. The role of the histone methyltransferase EZH2 in liver inflammation and fibrosis in STAM NASH mice. Biology. 2020;9(5):93. https://doi.org/10.3390/biology9050093
14. Chen Z, Du Y, Liu X, Chen H, Weng X, Guo J, et al. EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway. Oncol Lett. 2019;18(1):907–15. https://doi.org/10.3892/ol.2019.10359
15. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Amer Med Assoc (JAMA). 2013;310(20):2191–4. https://doi.org/10.1001/jama.2013.281053
16. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protocols. 2006;1(3):1559–82. https://doi.org/10.1038/nprot.2006.236
17. Michaelidou K, Tzovaras A, Missitzis I, Ardavanis A, Scorilas A. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. Int J Oncol. 2013;42(5):1770–7. https://doi.org/10.3892/ijo.2013.1860
18. Liu S, Zhuo L, Wang J, Zhang Q, Li Q, Li G, et al. METTL3 plays multiple functions in biological processes. Amer J Cancer Res. 2020;10(6):1631–46. PMID: 32642280
19. Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13(1):117. https://doi.org/10.1186/s13045-020-00951-w
20. Zhong H, Hao L, Li X, Wang C, Wu X. Anti-inﬂammatory role of trilobatin on lipopolysaccharide-induced acute lung injury through activation of AMPK/GSK3β-Nrf2 pathway. Signa Vitae. 2020;16(2):160–6. https://doi.org/10.22514/sv.2020.16.0075
21. Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R, et al. m(6) A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39(20):e104514. https://doi.org/10.15252/embj.2020104514
22. Li B, Zhu J, Meng L. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Mol Med Rep. 2019;19(2):877–84. https://doi.org/10.3892/mmr.2018.9716
23. Peng W, Li J, Chen R, Gu Q, Yang P, Qian W, et al. Upregulated METTL3 promotes metastasis of colorectal cancer via miR-1246/SPRED2/MAPK signaling pathway. J Exp Clin Cancer Res. 2019;38(1):393. https://doi.org/10.1186/s13046-019-1408-4
24. Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, et al. The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network. Oncogene. 2019;38(19):3667–80. https://doi.org/10.1038/s41388-019-0683-z
25. Zhang Y, Gu X, Li D, Cai L, Xu Q. METTL3 regulates osteoblast differentiation and inflammatory response via smad signaling and MAPK signaling. Int J Mol Sci. 2019;21(1):199. https://doi.org/10.3390/ijms21010199